IL124944A - Quinolonecarboxylic acid derivatives or their salts and pharmaceutical compositions containing them - Google Patents

Quinolonecarboxylic acid derivatives or their salts and pharmaceutical compositions containing them

Info

Publication number
IL124944A
IL124944A IL12494497A IL12494497A IL124944A IL 124944 A IL124944 A IL 124944A IL 12494497 A IL12494497 A IL 12494497A IL 12494497 A IL12494497 A IL 12494497A IL 124944 A IL124944 A IL 124944A
Authority
IL
Israel
Prior art keywords
salts
acid derivatives
pharmaceutical compositions
optionally substituted
compositions containing
Prior art date
Application number
IL12494497A
Other languages
English (en)
Other versions
IL124944A0 (en
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to IL14508197A priority Critical patent/IL145081A/xx
Publication of IL124944A0 publication Critical patent/IL124944A0/xx
Publication of IL124944A publication Critical patent/IL124944A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Indole Compounds (AREA)
IL12494497A 1996-02-09 1997-02-07 Quinolonecarboxylic acid derivatives or their salts and pharmaceutical compositions containing them IL124944A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL14508197A IL145081A (en) 1996-02-09 1997-02-07 Organoboron intermediates for quinolonecarboxylic acid derivatives or their salts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4793696 1996-02-09
PCT/JP1997/000317 WO1997029102A1 (fr) 1996-02-09 1997-02-07 Derives de l'acide quinolonecarboxylique et leurs sels

Publications (2)

Publication Number Publication Date
IL124944A0 IL124944A0 (en) 1999-01-26
IL124944A true IL124944A (en) 2003-06-24

Family

ID=12789268

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12494497A IL124944A (en) 1996-02-09 1997-02-07 Quinolonecarboxylic acid derivatives or their salts and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US6025370A (hu)
EP (1) EP0882725B1 (hu)
KR (1) KR100276477B1 (hu)
CN (2) CN1100053C (hu)
AT (1) ATE229950T1 (hu)
AU (1) AU711914B2 (hu)
CA (1) CA2242242C (hu)
DE (1) DE69717970T2 (hu)
DK (1) DK0882725T3 (hu)
ES (1) ES2188890T3 (hu)
HK (1) HK1039118B (hu)
HU (1) HU228567B1 (hu)
IL (1) IL124944A (hu)
NO (1) NO316666B1 (hu)
NZ (1) NZ330775A (hu)
PT (1) PT882725E (hu)
WO (1) WO1997029102A1 (hu)
ZA (1) ZA971023B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014214A1 (en) 1997-09-15 1999-03-25 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
TW593308B (en) 1997-10-27 2004-06-21 Toyama Chemical Co Ltd Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate
DK1070713T3 (da) * 1998-04-06 2006-12-27 Toyama Chemical Co Ltd Quinoloncarboxylsyrederivater eller salte deraf
JP4499846B2 (ja) * 1998-05-07 2010-07-07 富山化学工業株式会社 7−イソインドリン−キノロンカルボン酸誘導体の製造法並びにイソインドリン−5−ボロン酸誘導体の製造法
JP4549461B2 (ja) * 1998-08-31 2010-09-22 富山化学工業株式会社 7−ブロモ−キノロンカルボン酸誘導体の製造法
JP2000229946A (ja) * 1998-12-10 2000-08-22 Toyama Chem Co Ltd キノロンカルボン酸の製造法およびその中間体
CA2367373C (en) 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
PL212421B1 (pl) * 2002-03-12 2012-09-28 Bristol Myers Squibb Co Kompozycja farmaceutyczna w postaci zawiesiny kwasowego leku i sposób jej wytwarzania oraz sposób maskowania gorzkiego lub innego nieprzyjemnego smaku leku
WO2004113321A1 (ja) * 2003-06-19 2004-12-29 Daiichi Pharmaceutical Co., Ltd. 選択的なアミノ置換基導入法
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
EP1873134B1 (en) * 2005-03-03 2013-02-13 JNC Corporation Chlorofluorobenzene liquid crystalline compound, liquid crystal composition, and liquid crystal display element
CA2647457C (en) 2006-03-28 2011-05-24 The Procter & Gamble Company A hydride reduction process for preparing quinolone intermediates
MX2008012488A (es) 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
CN101298418B (zh) * 2008-06-13 2010-12-15 江苏康鹏农化有限公司 3-氧代-3-(2,4-二卤代-3-二氟甲氧基苯基)丙酸乙酯的制备方法
CN102212056A (zh) * 2010-04-09 2011-10-12 山东轩竹医药科技有限公司 新的双环喹诺酮类化合物
WO2013121439A2 (en) * 2012-02-15 2013-08-22 Glenmark Generics Limited Process for garenoxacin mesylate
GB201516614D0 (en) * 2015-09-18 2015-11-04 Redx Pharma Plc Antibacterial compounds
CN105837555B (zh) * 2016-03-31 2019-01-25 南京华威医药科技集团有限公司 加雷沙星及其中间体制备方法
CN111620901B (zh) * 2020-06-08 2023-03-21 蚌埠医学院第二附属医院 一种含硅氧烷基的氟喹诺酮化合物、其制备方法及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6199835A (ja) * 1984-10-22 1986-05-17 Shimadzu Corp 振動試験機の波形補正装置
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
JPH07300472A (ja) * 1992-12-28 1995-11-14 Korea Res Inst Chem Technol 新規キノロンカルボン酸誘導体およびその製造方法
JPH06199835A (ja) * 1993-01-08 1994-07-19 Hokuriku Seiyaku Co Ltd 8−ジフルオロメトキシキノリン−3−カルボン酸誘導体
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
JPH0848629A (ja) * 1994-08-08 1996-02-20 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤
NZ290946A (en) * 1994-08-12 1997-12-19 Toyama Chemical Co Ltd Quinolone- or naphthyridone-carboxylic acid derivatives

Also Published As

Publication number Publication date
CA2242242C (en) 2001-08-07
WO1997029102A1 (fr) 1997-08-14
CN1314355A (zh) 2001-09-26
AU711914B2 (en) 1999-10-21
NO316666B1 (no) 2004-03-29
IL124944A0 (en) 1999-01-26
NZ330775A (en) 1999-08-30
PT882725E (pt) 2003-04-30
DE69717970D1 (de) 2003-01-30
HK1039118A1 (en) 2002-04-12
EP0882725A1 (en) 1998-12-09
HUP9901966A3 (en) 2002-01-28
NO983625L (no) 1998-08-07
CN1100053C (zh) 2003-01-29
EP0882725A4 (en) 1999-05-06
DE69717970T2 (de) 2003-04-30
ATE229950T1 (de) 2003-01-15
KR19990082406A (ko) 1999-11-25
CN1210533A (zh) 1999-03-10
HK1039118B (zh) 2009-01-30
AU1670197A (en) 1997-08-28
HU228567B1 (en) 2013-04-29
US6025370A (en) 2000-02-15
NO983625D0 (no) 1998-08-07
KR100276477B1 (ko) 2000-12-15
CA2242242A1 (en) 1997-08-14
HUP9901966A2 (hu) 1999-09-28
EP0882725B1 (en) 2002-12-18
CN100395244C (zh) 2008-06-18
DK0882725T3 (da) 2003-01-13
ZA971023B (en) 1997-09-25
ES2188890T3 (es) 2003-07-01

Similar Documents

Publication Publication Date Title
IL124944A (en) Quinolonecarboxylic acid derivatives or their salts and pharmaceutical compositions containing them
HK1032969A1 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
PL334915A1 (en) Pyrrolidine derivatives exhibiting phospholipase a2 inhibiting activity
AU6052594A (en) New heterocyclic compounds
EP0900795A4 (en) HETEROCYCLICALLY SUBSTITUTED BENZENE DERIVATIVES AND HERBICIDES
EP0902007A4 (en) CHALCON DERIVATIVES AND MEDICINES THAT CONTAIN THEM
AU9281198A (en) Benzofuran derivatives
FI942499A0 (fi) Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
GR3021143T3 (en) Imidazole derivatives and pharmaceutical compositions containing the same.
NO921159L (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
ES2129123T3 (es) Nuevo derivado de bisoxadiazolidina.
EP1004290A3 (de) Kosmetische oder pharmazeutische Zubereitungen, enthaltend 1,3,5-Triazinderivate und Zinkoxid
ATE171622T1 (de) Antiallergische zusammensetzung enthaltend eine phosphorsäurediester-verbindung
EP0573659A4 (en) Pyrazolothiazolopyrimidine derivative

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired